Inactive Instrument
Heritage Cannabis Holdings Corp. Stock Canadian Securities Exchange
Equities
CANN
CA42727B1094
Pharmaceuticals
| Capitalization | 749K 1.02M | P/E ratio 2022 |
-1.08x | P/E ratio 2023 | -0.38x |
|---|---|---|---|---|---|
| Enterprise value | 5.28M 7.16M | EV / Sales 2022 |
1,322,235x | EV / Sales 2023 | 407,556x |
| Free-Float |
85.98% | Yield 2022 * |
-
| Yield 2023 | - |
More valuation ratios
* Estimated data
| Director | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
Jasmine Paige
DFI | Director of Finance/CFO | - | 23-08-13 |
Eoin Hegarty
COO | Chief Operating Officer | - | 23-02-07 |
| Manager | Title | Age | Since |
|---|---|---|---|
Clinton Sharples
CHM | Chairman | - | 13-05-28 |
Céline Arsenault
BRD | Director/Board Member | - | 19-02-07 |
| Chief Executive Officer | - | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -0.56% | +1.43% | -5.55% | +41.69% | 4.21B | ||
| +1.94% | -1.01% | -34.30% | -13.98% | 3.4B | ||
| +2.10% | +4.05% | +0.43% | +4.59% | 2.92B | ||
| +1.98% | +2.71% | -21.00% | +2.83% | 2.57B | ||
| +2.67% | +2.74% | -16.05% | -20.75% | 2.23B | ||
| -3.18% | +2.08% | +9.60% | +77.43% | 1.58B | ||
| +1.57% | +0.27% | -25.45% | -39.61% | 1.38B | ||
| +1.94% | -1.25% | -29.78% | -31.00% | 1.31B | ||
| +0.75% | 0.00% | +14.41% | -13.90% | 1.31B | ||
| Average | +1.02% | -0.05% | -11.97% | +0.81% | 2.32B | |
| Weighted average by Cap. | +1.06% | +0.05% | -12.86% | +5.29% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 29.57 40.1 | 29.79 40.41 |
| Net income | -24.24M -32.89M | -20.1M -27.26M |
| Net Debt | 11.54M 15.66M | 4.53M 6.15M |
More financial data
* Estimated data
Employees
2
Sector
Pharmaceuticals
